EU May Disclose Some Details Of COVID-19 Vaccine Contracts

Politicians Air Concerns Over Vaccine Hesitancy

The European Commission seems to be prepared to disclose some parts of the contracts it is signing with companies for coronavirus vaccines, but transparency campaigners say this might not be enough to engender trust in the vaccines among the population at large. 

Document, contract, review.
EU politicians and campaigners want scrutiny of COVID-19 vaccine contracts • Source: Shutterstock

In the face of growing pressure for transparency over the contracts it is negotiating with pharmaceutical companies for the supply of COVID-19 vaccines, the European Commission has agreed to consider disclosing some of the contents of those contracts, with certain "sensitive" information redacted.

Health Commissioner Stella Kyriakides told members of the European Parliament (MEPs) that the EU was aiming for a “diverse, common...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography